Chief Technologist

Sector: BiotechnologyReference: BBBH _ Chief Technologist - Synthetic Therapeutics (Peptides & Oligonucleotides)FTC until March 2028 | Glasgow | 64,394 - 84,394 + 491 Monthly Car AllowanceAbout the Role: We are seeking a Chief Technologist - Synthetic Therapeutics to provide strategic technical leadership across peptide and oligonucleotide technologies, helping shape future capability, support commercial growth, and drive innovation in one of the fastest-growing areas of advanced therapeutics. This is a highly influential role for a recognised subject matter expert who combines deep scientific expertise with strong market awareness and commercial insight. You will help identify future opportunities, advise on technology strategy, engage with customers and partners, and support the development of capabilities that address emerging industry needs. The successful candidate will act as a senior technical leader across both internal and external activities, supporting business development, customer engagement, technology strategy, and scientific delivery while helping build capability in peptides and oligonucleotides.What You'll Be Responsible For:Technical Leadership & Domain ExpertiseAct as the recognised technical authority in peptide and/or oligonucleotide chemistryProvide expert guidance across customer programmes, strategic initiatives, and capability development activitiesSupport scientists and technical teams with specialist knowledge and technical problem-solvingEnsure emerging scientific developments are translated into practical and commercially relevant applicationsTechnology Strategy & Capability DevelopmentShape future capability in synthetic therapeutics, identifying technology gaps, market opportunities, and investment prioritiesInform long-term technology strategy and help develop deliverable plans aligned to business objectivesAnticipate new developments within peptide and oligonucleotide technologies and assess their commercial relevanceSupport the translation of advanced chemistry into scalable and commercially viable capabilitiesMarket Engagement & Business DevelopmentWork closely with commercial and business development teams to identify and develop new opportunitiesEngage directly with customers, industry partners, investors, and stakeholders to understand market needsSupport proposal development, bid activities, and customer-facing technical discussionsContribute to technical and commercial assessments of new opportunities and partnershipsCapability Building & MentorshipMentor scientists and technical teams, helping build expertise across the organisationPromote knowledge sharing and capability development across internal and external networksSupport the development of future scientific leaders and specialistsFoster a culture of innovation and continuous learningAbout You You are a senior technical expert with deep knowledge of peptides, oligonucleotides, or synthetic therapeutic modalities, coupled with strong commercial awareness and an ability to influence strategic direction. You'll bring:Significant industrial experience within peptides and/or oligonucleotidesStrong expertise in areas such as:Peptide synthesis, modification, and conjugationComplex or constrained peptidesPeptide-drug conjugatesOligonucleotide chemistryOligo conjugatesModified backbones and delivery-enabled constructsA proven track record of translating scientific knowledge into commercially relevant capabilities and opportunitiesStrong understanding of market dynamics, customer needs, and future industry trendsExcellent stakeholder management, networking, and influencing skillsExperience operating at a strategic level within pharmaceutical, biotech, CDMO, or advanced therapeutics environments Desirable (but not essential):PhD or equivalent research background in peptide, oligonucleotide, or synthetic chemistry disciplinesExperience contributing to technology strategy and capability developmentExisting industry network within peptides, oligonucleotides, or related therapeutic modalitiesKnowledge of broader synthetic therapeutic approaches and emerging modalitiesMembership of relevant professional bodies and active engagement with the wider scientific communityImportantly, this role is not focused on routine GMP manufacturing operations. The emphasis is on strategic technical leadership, market engagement, capability development, and helping define where future investment and technological growth should occur.Why Join Us?Influence the future direction of peptide and oligonucleotide technology developmentShape capability in a rapidly growing area of advanced therapeuticsWork with leading scientific, commercial, and industry stakeholdersPlay a key role in identifying and developing future market opportunitiesHigh-profile position with significant external engagementCompetitive package including salary up to 84,394 plus monthly car allowanceLocation & Working PatternFTC until March 2028 (potential to extend)Hybrid working availableRegular engagement with customers, partners, and external stakeholdersTravel to industry events, customer meetings, and scientific forums as requiredGuidant, Carbon60, Lorien & SRG - The Impellam Group Portfolio are acting as an Employment Business in relation to this vacancy.